Objectif Peripheral Arterial Disease (PAD) is caused by the deposition of fatty material on the inner walls of peripheral arteries causing reducing perfusion and local nutrition to the muscles and skin. The condition affect 202 million people globally and is increasing at a rate of 20% per annum due to an aging population and epidemic growth of diabetes. The social costs amounts to $210 - 380 billion per annum. Behavioural changes such as smoking cessation, healthy nutrition and exercise is recommended to reduce impact and risk. When the condition worsens, patients ability to walk and exercise is reduced. When disease progress to critical limb ischemia (unbearable pain and chronic wounds), the patients follow a trajectory towards costly vascular surgery or amputation.FlowOx targets the gap in care with a patented, cost effective and clinically promising home treatment solution. In order to secure the successful introduction of FlowOx into the market by 2020, resources are required to fill the following gaps in innovation:1) strong clinical evidence of efficacy 2) health economic assessment 3) design for large scale manufacturing and 4) a validated commercial model Germany, UK and Scandinavia. These 4 challenges will be addressed in the FlowOx project over a 30-month period. The Fast Track to Innovation Pilot program was selected to support a resource demanding and technically challenging stage of the product roadmap. The support enables Otivio to join forces with a medical device manufacturer, Innokas Medical, Finland, and UK based Univ. of Salford and Univ. of Bangor with extensive experience in clinical and health economic studies. The FlowOx project enables Otivio and Innokas to enter the world-wide PAD market, gaining a strong market positon with a home care device for PAD treatment and expected sales of over €220 million within 5 years of launch. Champ scientifique medical and health sciencesclinical medicinesurgerymedical and health sciencesclinical medicineendocrinologydiabetesmedical and health scienceshealth sciencesnutritionmedical and health sciencesclinical medicineperipheral vascular diseasesocial scienceseconomics and businessbusiness and managementcommerce Programme(s) H2020-EC - Horizon 2020 Framework Programme Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2. - PRIORITY 'Industrial leadership' Thème(s) FTIPilot-01-2016 - Fast Track to Innovation Pilot Appel à propositions H2020-FTIPilot-2016 Voir d’autres projets de cet appel Sous appel H2020-FTIPilot-2016-1 Régime de financement IA - Innovation action Coordinateur OTIVIO AS Contribution nette de l'UE € 876 000,00 Adresse GAUSTADALLEEN 21 0349 OSLO Norvège Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Norge Oslo og Viken Oslo Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 1 251 428,58 Participants (3) Trier par ordre alphabétique Trier par contribution nette de l'UE Tout développer Tout réduire INNOKAS MEDICAL OY Finlande Contribution nette de l'UE € 680 750,00 Adresse VIHIKARI 10 90440 Kempele Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Manner-Suomi Pohjois- ja Itä-Suomi Pohjois-Pohjanmaa Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 972 500,00 THE UNIVERSITY OF SALFORD Royaume-Uni Contribution nette de l'UE € 375 000,00 Adresse THE CRESCENT 43 M5 4WT Salford Voir sur la carte Région North West (England) Greater Manchester Greater Manchester South West Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 375 000,00 BANGOR UNIVERSITY Royaume-Uni Contribution nette de l'UE € 148 750,00 Adresse COLLEGE ROAD LL57 2DG Bangor Voir sur la carte Région Wales West Wales and The Valleys Gwynedd Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 148 750,00